Shareholders' Deficit (Details Textual)
|
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
Jan. 11, 2016
USD ($)
shares
|
Aug. 09, 2015 |
Oct. 07, 2014
USD ($)
shares
|
Nov. 30, 2018
$ / shares
shares
|
Oct. 31, 2017
USD ($)
shares
|
May 31, 2017
USD ($)
shares
|
Apr. 30, 2017
$ / shares
|
Apr. 04, 2017
USD ($)
shares
|
Mar. 16, 2017
shares
|
Oct. 31, 2016
shares
|
Oct. 18, 2016
USD ($)
$ / shares
shares
|
Aug. 31, 2015
USD ($)
shares
|
Mar. 31, 2015
USD ($)
$ / shares
|
Dec. 30, 2014
USD ($)
$ / shares
shares
|
Jan. 29, 2012
USD ($)
shares
|
Jan. 29, 2012
ILS (₪)
₪ / shares
shares
|
Mar. 31, 2014
USD ($)
shares
|
Mar. 31, 2014
ILS (₪)
shares
|
Dec. 31, 2018
USD ($)
shares
|
Dec. 31, 2017
USD ($)
shares
|
Dec. 31, 2016
USD ($)
shares
|
Dec. 31, 2015
USD ($)
shares
|
Dec. 31, 2018
₪ / shares
|
Dec. 31, 2017
₪ / shares
|
Oct. 31, 2017
₪ / shares
|
Dec. 31, 2016
ILS (₪)
₪ / shares
shares
|
Mar. 31, 2015
ILS (₪)
|
Oct. 07, 2014
₪ / shares
|
Apr. 22, 2010
₪ / shares
shares
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,230,162
|
70,087,141
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | ₪ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
₪ 0.01
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 562,553
|
|
$ 566,569
|
|
|
|
|
|
|
|
|
|
Ordinary shares, authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000,000
|
1,000,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
10,000,000
|
|
|
|
|
|
10,000,000
|
|
|
|
Preferred stock, par value | ₪ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
|
₪ 0.01
|
|
|
|
Issuance of warrants | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,106,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 80,345
|
$ 562,604
|
[1] |
$ 566,569
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,672
|
113,758
|
[1] |
210,180
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 226
|
|
$ 273
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 6 months
|
|
2 years 6 months
|
[2] |
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
100.00%
|
[3] |
|
|
|
|
|
|
|
|
Adjustment of warrants granted for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 34,272
|
|
$ 23,233
|
|
|
|
|
|
|
|
Related stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,750
|
|
|
|
|
|
|
|
|
|
Company issued ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,215,934)
|
$ (1,339,633)
|
|
(403,949)
|
|
$ (527,510)
|
|
|
|
|
|
|
|
Exercised warrants to common stock | shares |
|
|
|
3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock and warrants for services or claims |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
166,500
|
[1] |
|
|
|
|
|
|
|
|
|
|
Fair value of warrants liability classified to equity in connection with warrants exercised during the period (see Note 9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128,965
|
297,200
|
[1] |
|
|
|
|
|
|
|
|
|
|
Provision amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
Compensation expenses include research and development expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 459,184
|
$ 720,527
|
|
$ 317,907
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,518,406
|
|
3,106,000
|
|
|
|
|
|
|
|
Share price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of units, description |
|
|
|
|
|
|
|
|
|
|
|
|
each unit consisting of: (A) 1 ordinary share par value NIS 0.01 and (B) 1 three-year warrant to purchase 1 ordinary share par value NIS 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 903,681
|
|
$ 621,200
|
|
|
|
|
|
|
|
Description on warrant exercise price |
|
|
|
|
|
|
The Company offered to the holders of the warrants to lower the exercise price of the warrants from $0.5 per share to $0.4 per share for a limited period of time of 8 weeks.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised warrants to common stock | shares |
|
|
|
|
|
1,665,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised warrants to common stock, value |
|
|
|
|
|
$ 666,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised warrants to common stock, net cash |
|
|
|
|
|
$ 599,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercises in period | shares |
|
|
|
|
|
|
|
81,432
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
|
|
|
|
|
|
|
$ 226
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited non-vested options | shares |
|
|
|
|
|
|
|
228,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of capital units | ₪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 100,000
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of capital units | ₪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 10,000,000
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of private placement |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of warrants | shares |
|
|
|
|
|
|
|
|
|
|
620,521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, Expiration term |
|
|
|
|
|
|
|
|
|
|
18 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment of warrants granted for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (45,746)
|
|
|
|
|
|
|
|
|
|
Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | ₪ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
|
|
|
|
Debt conversion converted instrument , shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,000,000
|
27,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt conversion converted instrument , shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 160,987
|
₪ 600,000
|
|
₪ 200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
|
|
$ 625,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
1,061,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor [Member] | Share Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, par value | (per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock based expense | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of stock, shares | shares |
|
|
|
|
|
|
|
|
3,333,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercises in period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Company issued ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,424
|
|
8,810
|
|
|
|
|
|
|
|
Stock-based compensation, shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,379
|
|
237,276
|
|
|
|
|
|
|
|
|
|
Conversion of preferred shares into ordinary shares, shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,351,850)
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares of NIS 0.01[Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock based expense | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350,000
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,015
|
|
$ 11,669
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,061,125
|
|
4,518,406
|
|
|
|
|
|
|
|
|
|
Exercises in period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
620,521
|
81,432
|
|
103,428
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,656
|
$ 226
|
|
$ 273
|
|
|
|
|
|
|
|
|
|
Related stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Company issued ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 190,679
|
$ 184,961
|
|
$ 166,723
|
|
154,781
|
|
|
|
|
|
|
|
Stock-based compensation, shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred shares into ordinary shares, shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,351,850
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares of NIS 0.01[Member] | Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt conversion converted instrument , shares | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
123,900
|
123,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt conversion converted instrument , shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 57,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
Ordinary Shares of NIS 0.01[Member] | Investor [Member] | Share Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, value, new issues |
|
|
$ 350,593
|
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
9,000,000
|
|
|
|
|
|
|
|
|
|
|
606,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares of NIS 0.01[Member] | Investor [Member] | Share Purchase Agreement One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
|
|
|
|
|
|
|
18,120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued during period, shares, new issues | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600,000
|
|
|
4,518,406
|
|
3,106,000
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
$ 0.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercises in period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81,432
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 226
|
|
|
|
|
|
|
|
|
|
Warrant [Member] | Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested in period | shares |
|
|
|
|
|
|
|
|
|
25,855
|
232,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
1.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
67000.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liability |
|
|
|
|
|
|
|
|
|
|
$ 91,490
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mr.Zigdon [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock based expense | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
237,276
|
|
96,195
|
|
|
|
|
|
|
|
Ordinary shares, issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,379
|
|
|
|
|
|
|
|
|
|
|
3,000,000
|
Ordinary shares, par value | ₪ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 0.01
|
Exercises in period | shares |
103,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options exercised |
$ 273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Deficit (Textual) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued share capital, percentage |
|
5.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|